GL1X · GenesisL1 explorer

MolNFT v1 · #26045 · protein

Crystal structure of human peptidylarginine deiminase TYPE4 (PAD4) in complex with benzoyl-L-arginine amide

1WDA · Protein-arginine deiminase type IV: “Crystal structure of human peptidylarginine deiminase TYPE4 (PAD4) in complex with benzoyl-L-arginine amide”. X-ray diffraction, 3 ligands (BAG, CA, SO4), 2 pockets (best druggability 0.55).…

PDB
1WDA
Type
protein
Length
628 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein-arginine deiminase type IV
EC
3.5.3.15
UniProt
Q9UM07
Ligands
BAG, CA, SO4
Pockets
2 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 21% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein-arginine deiminase type IV (EC 3.5.3.15)protein62821% helix, 36% strandQ9UM07

Ligands and binding sites

  • BAG · N-[(E)-2-amino-1-(3-{[amino(imino)methyl]amino}propyl)-2-hydroxyvinyl]benzamide · ligand · chains A
  • CA · Calcium ion · metal · 5 copies · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11600.550.8129BAG
2610.300.7517empty

Compared structures

  • 1WDA · Crystal structure of human peptidylarginine deiminase type4 (PAD4) in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UM07 · AlphaFold monomer V2.0 prediction for protein-arginine deiminase type-4 (Q9UM07) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.